ArticleFrontiers in oncology2024

Corrigendum: Bruceine H mediates EGFR-TKI drug persistence in NSCLC by Notch3-dependent β-catenin activating FOXO3a signaling.

Jiahui Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.